Outset Medical, INC 10-Q quarterly reports

Outset Medical reported flat revenue for Q2 2026 compared to the prior year, with a notable improvement in gross margin driven by service revenue, though net losses and operating cash burn persist.

Outset Medical reports a net loss of $19.0 million for Q1 2026, reflecting ongoing operational restructuring and market challenges.

Outset Medical posted 3% revenue growth, a 510 bps gross margin expansion, and a sharply reduced quarterly loss while shoring up liquidity through debt refinancing and preferred equity conversion.

Outset Medical, Inc. reported a significant reduction in net losses and improved gross margins for the first half of 2025, driven by revenue growth and cost optimization efforts.

Outset Medical's Q1 2025 results show revenue growth, reduced operating expenses, and strategic financing moves including a new term loan and preferred stock issuance.

Outset Medical's Q3 2024 results show a decrease in revenue compared to the previous year, alongside ongoing restructuring and cost-cutting measures.

Outset Medical's Q2 2024 revenue decreased by 24% year-over-year, primarily due to lower console sales, while the company focuses on enterprise selling and cost optimization.

Outset Medical's first quarter 2024 results show a decrease in product revenue, offset by growth in service revenue, and a net loss of $39.9 million.